Warts Therapeutics Market Analysis and Scope (2022 to 2028)
Warts Therapeutics Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1.83 Billion |
Market Size by 2028 | US$ 2.31 Billion |
Global CAGR (2021 - 2028) | 3.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Warts Therapeutics Market – by Type
- Common Warts
- Genital Warts
- Flat Warts
- Others
Warts Therapeutics Market – by Treatment
- Physical Destruction
- Cryotherapy
- Surgical Removal
- Laser Treatment
- Immunomodulation
- Interferons
- Retinoids
- Zinc
- Chemical Destruction
- Bleomycin
- Cantharidin
- Salicylic Acid
- Others
Warts Therapeutics Market – by End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Warts Therapeutics Market– by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Bausch Health Companies Inc.
- Nielsen BioSciences, Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Novan, Inc.
- Scholl's Wellness Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Verrica Pharmaceuticals Inc.
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc